<p>This activity was supported by an educational grant from Merck & Co., Inc.. Please go to  ⁠<a href="http://academiccme.com/EPCPAH" target="_blank" rel="noopener noreferer">academiccme.com/EPCPAH</a> and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.</p>

This activity was supported by an educational grant from Merck & Co., Inc.. Please go to ⁠academiccme.com/EPCPAH and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.

<p>This activity was supported by an educational grant from Merck &amp; Co., Inc.. Please go to&nbsp;&nbsp;⁠<a href="http://academiccme.com/EPCPAH" rel="noopener noreferrer">academiccme.com/EPCPAH</a>&nbsp;and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.</p>

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

Enjoy Jointly Accredited Continuing Medical Education podcasts developed by AcademicCME in several advancing disease states. These programs are developed to bring the practicing clinician current with the latest science and provide optimal strategies on applying this science to practice

Share The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

Sign up to save your podcasts

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

More shows like AcademicCME Podcast

The Medbullets Step 1 Podcast